Sun.Oct 02, 2022

article thumbnail

How Pharmacists Can Prepare Today for the 2022-2023 Flu Season

Drug Topics

Jordan Cardinal, EM/CC PharmD, a Medical Science Liaison in Integrated Diagnostic Solutions at BD, joins Drug Topics® to discuss the current outlook on the upcoming 2022-2023 flu season, and how the prevalence of the BA.5 variant of the SARS-CoV-2 virus might affect the health care outlook over the coming months.

98
article thumbnail

Growth in Cell and Gene Therapy Market

BioPharm

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Expert: ‘We All Hold Implicit Biases’ That May Contradict Explicit Beliefs, Impact Patient Health

Pharmacy Times

As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.

65
article thumbnail

Biologic Standards in the Pharmacopoeias: An Update

BioPharm

Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.

75
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

V&A drops financial ties with Sackler family over links with opioids

The Guardian - Pharmaceutical Industry

London museum bows to years of pressure and removes signs bearing name of family associated with OxyContin crisis Campaigners calling for the name Sackler to be dropped from cultural landmarks are celebrating this weekend. Their smiles mark five years of demonstrations and dramatic stunts as another major arts institution – London’s Victoria and Albert Museum – takes down signs acknowledging the financial contribution from this wealthy family.

65
article thumbnail

Advances in Real-Time Supply Chain Operation Technology Can Address Drug Product Security Challenges

BioPharm

Advances in Real-Time Supply Chain Operation Technology Can Address Drug Product Security Challenges.

105
105

More Trending

article thumbnail

Comparing Online PANRE Exam Review Question Banks

Board Vitals - Pharmacist

Are you preparing to take your PANRE exam? As part of the NCCPA’s certification maintenance process, PA-C designees must pass the Physician Assistant National Recertifying Exam (PANRE) by the end of the tenth year of their certification maintenance cycle. With so many different Online PANRE exam review question banks available, how do you know which one best fits your needs?

article thumbnail

Considerations for Simplifying Downstream Processes

BioPharm

A simplified downstream process can save time and costs but requires enabling technologies.

97
article thumbnail

Introducing a New Concept for Value-Driven Acceleration in Biopharma Development

BioPharm

Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.

52
article thumbnail

A New Era of Biomarker Discovery: Harnessing the Clinical Power of AI-Driven Glycoproteomics

BioPharm

Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.

40
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Reformulating Success

BioPharm

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

52
article thumbnail

Weighing the Benefits of Fermentation for New Biotherapies

BioPharm

The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.

59
article thumbnail

Focus on Fill and Finish

BioPharm

Both demand for and investment in fill/finish capacity continue to rise.

59
article thumbnail

Improving Sterility Using Blow-Fill-Seal Technology

BioPharm

BFS technology can help maintain sterility during the biologics manufacturing process.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.